---
title: Buy Cabergoline 0.25mg | 0.5mg Pills Online
description: Cabergoline 0.25mg or 0.5mg pills manage high prolactin levels and related conditions. Order from our secure online pharmacy for authentic product.
type: product
language: en 
url: https://liabilis.com/order-cabergoline-online-en.html
availability: in_stock
shipping:
  - type: Standard Airmail
    price: 10.00
    currency: USD
    area: Worldwide
    time: 14-21 days
  - type: Tracked Express
    price: 30.00
    currency: USD
    area: Worldwide
    tracking: true
    time: 5-9 days
price_min: 73.44
price_max: 340.99
currency: USD
offers:
  - name: 0.25mg x 8 pills
    price: 77.99
  - name: 0.25mg x 12 pills
    price: 103.99
  - name: 0.5mg x 8 pills
    price: 114.99
  - name: 0.25mg x 16 pills
    price: 129.99
  - name: 0.5mg x 12 pills
    price: 73.44
  - name: 0.25mg x 20 pills
    price: 158.99
  - name: 0.5mg x 16 pills
    price: 178.99
  - name: 0.5mg x 32 pills
    price: 340.99
---

# Buy Cabergoline 0.25mg | 0.5mg Pills Online

Cabergoline is a dopamine agonist used for adults with hyperprolactinemia to lower prolactin levels, treating conditions like prolactinomas and related symptoms. It supports hormonal balance. Available in 0.25mg or 0.5mg pills through our reliable online pharmacy.

## Pricing and Options

| Dosage | Pack Size | Price (USD) | Price Per Pill | Status |
| :--- | :--- | :--- | :--- | :--- |
| **0.25mg** | 8 pills | **$77.99** | $9.81 | In Stock |
| **0.25mg** | 12 pills | **$103.99** | $8.64 | In Stock |
| **0.5mg** | 8 pills | **$114.99** | $14.35 | In Stock |
| **0.25mg** | 16 pills | **$129.99** | $8.12 | In Stock |
| **0.5mg** | 12 pills | **$73.44** | $6.12 | In Stock |
| **0.25mg** | 20 pills | **$158.99** | $7.96 | In Stock |
| **0.5mg** | 16 pills | **$178.99** | $11.21 | In Stock |
| **0.5mg** | 32 pills | **$340.99** | $10.65 | In Stock |


[Buy Now](https://liabilis.com/order-cabergoline-online-en.html)

## Introduction 
Cabergoline is a synthetic ergot-derived dopamine agonist used primarily to lower high levels of prolactin. The active ingredient is cabergoline, formulated as oral tablets available in 0.25 mg and 0.5 mg strengths. It belongs to the class of dopaminergic agents that act on dopamine-2 (D₂) receptors. In addition to its approved role in treating hyperprolactinemia, cabergoline is sometimes employed off-label for movement disorders such as Parkinson’s disease and restless-leg syndrome.

## Quick Reference Facts 
**Active Ingredient** 
: Cabergoline 

**Form** 
: pill 0.25 mg | 0.5 mg 

**Primary and Off-Label Uses** 
: • Treatment of hyperprolactinemia (prolactin-producing pituitary tumors) 
: • Management of Parkinson’s disease adjunctively (off-label) 
: • Relief of restless-leg syndrome symptoms (off-label) 

## What is Cabergoline? 
Cabergoline is a long-acting dopamine-2 receptor agonist marketed as a generic medication. The drug is the generic version of products that contain the active compound cabergoline, most notably the brand name Dostinex. Because it is generic, cabergoline is bioequivalent to the branded formulation and is prescribed for the same indications at comparable efficacy. The molecule was first synthesized in the 1980s and received regulatory approval for prolactin-lowering therapy in the early 1990s. Generic production is overseen by multiple manufacturers worldwide, each adhering to the same quality standards required for the reference brand.

## How Cabergoline Works 
Cabergoline stimulates dopamine-2 receptors on pituitary lactotroph cells, inhibiting prolactin secretion. Dopamine is the physiological inhibitor of prolactin release; by acting as a potent agonist, cabergoline reduces circulating prolactin levels, leading to tumor shrinkage and restoration of gonadal function. The drug exhibits a high affinity for D₂ receptors and a long plasma half-life (approximately 63-68 hours), allowing dosing as infrequent as twice weekly. Metabolism occurs primarily via hepatic CYP3A4, and the metabolites are excreted renally. The prolonged half-life provides steadier receptor occupancy compared with shorter-acting agents, contributing to its efficacy in chronic prolactin suppression.

## Conditions Treated with Cabergoline 

- **Hyperprolactinemia (prolactin-secreting pituitary adenomas)** 
 Cabergoline reduces prolactin production, decreasing tumor size in most patients and restoring menstrual cycles, fertility, and libido. 

- **Acromegaly (adjunctive therapy)** 
 In selected cases, cabergoline may aid in controlling growth hormone excess when combined with standard treatments, although this is not an FDA-approved indication. 

- **Parkinson’s disease (off-label adjunct)** 
 By stimulating central dopamine receptors, cabergoline can improve motor symptoms when used alongside levodopa, but safety monitoring is essential because of potential cardiac valve effects. 

- **Restless-leg syndrome (off-label)** 
 Dopaminergic activation alleviates uncomfortable leg sensations and urge to move, offering an alternative when first-line agents are ineffective. 

## Is Cabergoline the Right Medication for You? 
Cabergoline is most appropriate for adults diagnosed with prolactin-secreting pituitary tumors who require medical suppression of prolactin. It is also considered for patients who cannot tolerate bromocriptine, another dopamine agonist, due to side-effects. Candidates should have normal cardiac valve function, as cabergoline has been linked to valvulopathy at high cumulative doses. Contraindications include uncontrolled hypertension, known hypersensitivity to ergot derivatives, and pregnancy; women who are pregnant or planning pregnancy should avoid cabergoline. Patients with severe liver impairment may require dose adjustments or alternative therapies. A thorough evaluation by an endocrinologist or neurologist is recommended to confirm suitability.

## Buying Cabergoline from [our online pharmacy](https://liabilis.com/order-cabergoline-online-en.html) 

### Why Choose Our Service? 
Accessing cabergoline can be challenging when local pharmacies have limited stock or when insurance coverage raises out-of-pocket costs. Our platform offers a streamlined way to obtain the medication discreetly and affordably.

### Quality & Safety Assurance 
We partner with licensed international pharmacies to ensure quality and authenticity. Every batch is sourced from manufacturers that comply with Good Manufacturing Practice (GMP) standards and undergo independent verification.

### Pricing & Access 
Because cabergoline is available as a generic, [our online pharmacy](https://liabilis.com/order-cabergoline-online-en.html) can provide it at prices close to wholesale cost, often markedly lower than brand-name equivalents. This reduces the financial barrier for long-term therapy.

### Discreet Delivery 
Orders are packaged in unmarked envelopes and shipped via express courier (typically within 7 days) or standard airmail (approximately 3 weeks). Privacy is maintained throughout the fulfillment process.

## Use: Dosing, Missed Dose, Overdose 

- **Standard Dosing** 
 • Initial therapy usually starts with 0.25 mg taken orally twice weekly. 
 • After 4-6 weeks, the dose may be increased to 0.5 mg twice weekly based on prolactin levels and tolerability. 

- **Missed Dose** 
 • If a scheduled dose is forgotten, take it as soon as remembered unless the next dose is due within 12 hours; in that case, skip the missed dose and resume the regular schedule. Do not double-dose. 

- **Overdose Management** 
 • Symptoms of overdose can include nausea, vomiting, severe dizziness, and hypotension. 
 • Seek immediate medical attention or call emergency services. Provide details of the amount ingested and the time of ingestion. 

- **Practical Precautions** 
 • Cabergoline may be taken with or without food; however, consistent timing helps maintain stable blood levels. 
 • Alcohol can amplify dizziness and should be avoided while on therapy. 
 • Operating heavy machinery or driving is discouraged until the individual knows how cabergoline affects them. 

## Safety Information 

### ⚠️ Who Should Not Take Cabergoline 
- Patients with known hypersensitivity to ergot alkaloids. 
- Individuals with uncontrolled hypertension (BP > 140/90 mm Hg). 
- Patients with a history of cardiac valvular disease or fibrotic disorders. 
- Pregnant or breastfeeding women. 

### Common Side Effects 
- Nausea (≈20% of users) - usually mild and transient. 
- Headache (≈15%) - can be managed with acetaminophen. 
- Dizziness or light-headedness - advise rising slowly from seated positions. 

### Serious Side Effects (Seek Immediate Medical Help) 
- Signs of valvular heart disease: shortness of breath, swelling of ankles, new heart murmur. 
- Severe orthostatic hypotension leading to fainting. 
- Hallucinations or severe confusion. 

### Drug & Food Interactions 
- **CYP3A4 inhibitors (e.g., ketoconazole, erythromycin)** - may increase cabergoline plasma levels; dose reduction may be required. 
- **Antihypertensives** - additive blood-pressure-lowering effect; monitor BP closely. 
- **Antipsychotics that block dopamine receptors** - can diminish cabergoline’s efficacy. 

## Off-Label and Investigational Uses of Cabergoline 
Cabergoline is sometimes used off-label for Parkinson’s disease as an adjunct to levodopa, supported by small-scale studies indicating improvement in motor fluctuations. It has also been explored for treating restless-leg syndrome, where dopaminergic stimulation reduces sensory discomfort. Limited evidence suggests potential benefits in reducing insulin resistance in women with polycystic ovary syndrome, though this remains investigational. All off-label applications should be undertaken only under specialist supervision, with careful monitoring for cardiac valve effects and other risks.

## Storage & Handling 
- Store tablets at 20-25 °C (68-77 °F); excursions between 15-30 °C are acceptable. 
- Keep the container tightly closed and protect from moisture and direct sunlight. 
- Do not use tablets after the printed expiration date. 
- Dispose of unused medication through a pharmacy take-back program or according to local hazardous waste regulations.

## Frequently Asked Questions 

**Practical Use & Lifestyle** 

- **Can I travel internationally with cabergoline tablets?** 
 Yes, but keep the medication in its original labeled container, carry a copy of the prescription, and be aware of the destination country’s import regulations for prescription drugs. 

- **Should I take cabergoline at the same time each day?** 
 Consistency improves steady drug levels, so taking the doses on the same days each week (e.g., Monday and Thursday) is advisable. 

- **Is it safe to consume caffeine while on cabergoline?** 
 Moderate caffeine intake does not significantly interact with cabergoline, but excessive amounts may worsen nausea in sensitive individuals. 

**Product & Formulation Details** 

- **What do cabergoline tablets look like?** 
 Generic 0.25 mg tablets are typically white, round, and debossed with the dosage strength; 0.5 mg tablets are often larger and may have a different imprint depending on the manufacturer. 

- **Can the tablets be split or crushed?** 
 The tablets are not formulated for extended-release; however, splitting 0.5 mg tablets to achieve a 0.25 mg dose is acceptable if a scoring line is present. Crushing is discouraged as it may affect absorption. 

**Regulatory & Safety Nuances** 

- **Will cabergoline show up on a standard drug test?** 
 Cabergoline is not part of typical employment drug-screening panels, which focus on substances of abuse. 

- **Are there special considerations for elderly patients?** 
 Older adults may be more prone to orthostatic hypotension and valvular heart disease; low starting doses and regular cardiac monitoring are recommended. 

- **Is cabergoline prohibited in competitive sports?** 
 The World Anti-Doping Agency lists dopamine agonists as prohibited substances in certain contexts; athletes should consult their governing body before use. 

**Scientific & Clinical Curiosity** 

- **How does cabergoline differ from bromocriptine?** 
 Cabergoline has a longer half-life, higher D₂ receptor selectivity, and is generally better tolerated, allowing twice-weekly dosing versus daily bromocriptine. 

- **What key trial established cabergoline’s efficacy for prolactinomas?** 
 A pivotal randomized controlled trial published in *The New England Journal of Medicine* (1995) demonstrated superior prolactin normalization and tumor shrinkage with cabergoline compared with placebo. 

- **Has cabergoline been evaluated for heart valve safety?** 
 Large cohort studies have linked high cumulative doses (> 3 mg per week for > 4 years) with increased valvular regurgitation; routine echocardiography is advised for long-term users. 

## Glossary 

**Dopamine-2 (D₂) Receptor** 
: A subtype of dopamine receptor predominantly located in the pituitary gland and basal ganglia; activation inhibits prolactin secretion and modulates movement. 

**Hyperprolactinemia** 
: Elevated blood levels of prolactin, often caused by pituitary adenomas, leading to reproductive and sexual dysfunction. 

**Valvulopathy** 
: Disease or dysfunction of the heart valves, which can result from fibrotic changes induced by certain medications, including high-dose ergot derivatives. 

**Bioequivalence** 
: Demonstration that a generic product delivers the same amount of active ingredient to the bloodstream as the reference brand, within an accepted range. 

**Half-Life** 
: The time required for the plasma concentration of a drug to decrease by 50%; influences dosing frequency. 

## Disclaimer 

The information provided about **Cabergoline** is intended for general educational purposes and does not substitute professional medical consultation. All therapeutic decisions, including the use of Cabergoline for off-label indications, should be made under the direct supervision of a qualified healthcare provider. Readers are presumed to be competent adults capable of making informed health choices. [our online pharmacy](https://liabilis.com/order-cabergoline-online-en.html) supplies Cabergoline for individuals who may encounter limited availability through conventional pharmacies, encounter insurance barriers, or seek cost-effective generic options. Prior to initiating, adjusting, or stopping any medication, you should discuss the plan with your physician.